TomoTherapy Incorporated, maker of advanced radiation therapy solutions for the treatment of cancer and other diseases, today announced that a special meeting of shareholders will be held on Thursday, June 9, 2011 to vote on the proposed acquisition by Accuray (NASDAQ: ARAY). Shareholders as of the close of business on the record date of May 10, 2011 will be entitled to vote on the proposed transaction at the special meeting.
TomoTherapy also announced that the Securities and Exchange Commission (“SEC”) declared effective the registration statement on Form S-4 containing the proxy statement/prospectus that will be mailed to TomoTherapy shareholders in connection with the June 9 meeting. The TomoTherapy special meeting of shareholders will be held at 8:00 a.m. CDT on Thursday, June 9, 2011 at TomoTherapy’s administrative offices located at 1212 Deming Way, Madison, WI 53717.
